Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6528661
APP PUB NO 20020099224A1
SERIAL NO

10037412

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a process for preparing atorvastatin hemi-calcium from an atorvastatin ester derivative with calcium hydroxide. The process is conveniently incorporated into a process for preparing atorvastatin hemi-calcium from an acetonide protected, ester protected .beta.,.delta.-dihydroxy heptanoic acid precursor compound by a first acid hydrolysis step followed by base hydrolysis with calcium hydroxide. The latter process may be performed as a one-pot process.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TEVA PHARMACEUTICALS USA INC1090 HORSHAM ROAD NORTH WALES PA 19454-1090

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ishai, Eti Netanya, IL 2 40
Lidor-Hadas, Ramy Kfar Saba, IL 34 295
Lifshitz, Revital Herzlia, IL 15 108
Niddam, Valerie Even-Yeouda, IL 15 88

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation